Clinical trial
Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or…
NCT00079638 · Kos Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00079638 |
|---|---|
| Title | Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL |
| Official title | Comparative Efficacy Evaluation of Lipid Levels When Treated With Niaspan and Statin or Other Lipid-Modifying Therapies |
| Lead sponsor | Kos Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Dyslipidemia, Coronary Heart Disease, Atherosclerosis, Stroke, Diabetes |
| Intervention type | Drug |
| Interventions | Niacin, Atorvastatin, Simvastatin, Ezetimibe, Rosuvastatin |
| Enrollment | 300 |
| Start date | Apr 1, 2004 |
| Completion | May 1, 2005 |
| First posted | Mar 12, 2004 |
| Last update posted | Nov 1, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: